Substance / Medication

Alatrofloxacin mesylate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

13 trials linked to this intervention

13
Total Trials
3
Recruiting
5
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Phage Therapy in Bacterial Pneumonia Models: A Systematic Review and Meta-Analysis.
Rahman Mohammad Akhlaquer, Verma Kapil Kumar, Posa Mahesh Kumar · Comb Chem High Throughput Screen · 2025
PMID: 38357944Meta-Analysis
Effectiveness of MenB-4C Vaccine Against Gonorrhea: A Systematic Review and Meta-analysis.
Abara Winston E, Kirkcaldy Robert D, Bernstein Kyle T et al. · J Infect Dis · 2025
PMID: 39082700Meta-AnalysisFull text (PMC)
Efficacy of Doxycycline as Preexposure and/or Postexposure Prophylaxis to Prevent Sexually Transmitted Diseases: A Systematic Review and Meta-Analysis.
Boschiero Matheus Negri, Sansone Nathália Mariana Santos, Matos Laura Ribeiro et al. · Sex Transm Dis · 2025
PMID: 39316078Meta-Analysis
Effectiveness of macrolides as add-on therapy to beta-lactams in community-acquired pneumonia: A meta-analysis of randomized controlled trials.
Prizão Vitória Martins, Martins Otavio Cosendey, de Hollanda Morais Beatriz Austregésilo de Athayde et al. · Eur J Clin Pharmacol · 2025
PMID: 39551892Meta-Analysis
The global prevalence of Chlamydia trachomatis genital infection in pregnant women: a meta-analysis.
Salari Nader, Olfat Newsha, Ghasemi Hooman et al. · Arch Gynecol Obstet · 2025
PMID: 39821423Meta-AnalysisFull text (PMC)
Risk factors for drug-resistant pathogens in community-acquired pneumonia: systematic review and meta-analysis.
Nakagawa Natsuki, Katsurada Masahiro, Fukuda Yosuke et al. · Eur Respir Rev · 2025
PMID: 40107661Meta-AnalysisFull text (PMC)
Corticosteroids in critically ill patients with community-acquired pneumonia: A systematic review and Bayesian meta-analysis.
Chua Wei Yu, Chew Natalie, Iyer Shruthi C et al. · Ann Acad Med Singap · 2024
PMID: 39636194Meta-Analysis
Compatibility of alatrofloxacin mesylate with commonly used drugs during Y-site delivery.
Voytilla K L, Rusho W J, Tyler L S · Am J Health Syst Pharm · 2000
PMID: 10938984Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Alatrofloxacin mesilate (substance)
SNOMED CT
116543002
UMLS CUI
C0724517

Clinical Data

This intervention maps to 12 entities in the Healos knowledge graph.

12
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
13
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.